LCPUFA
Dietary Supplementpremature infant formula supplemented with LCPUFA
NCT Number: NCT01140243
The purpose of this study is to compare the efficacy and nutritional suitability of 2 infant formulas supplemented with different levels of LCPUFA, for premature infants following discharge from Hospital.
Looking for future studies?
Notify Me2 week–6 week
All sexes
Interventional
Not applicable
Neonatal Intensive Care Unit, Barzilai Medical Center, Ashkelon, Israel
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
premature infant formula supplemented with LCPUFA
Time frame: 12 weeks
anthropometric measure will be taken at the time of recruitment and on the following 4, 8 and 12 weeks
Materna Laboratories
Industry
Efficacy and Suitability of Infant Formula With a Special Fat Formulation for Premature Infants Following Discharge From Hospital Following Discharge From Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07604818
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Lyon, Rhone, France
View Trial DetailsNCT01698840
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Houston, Texas, United States
View Trial DetailsNCT02943746
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Houston, Texas, United States
View Trial DetailsNCT07137741
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Guli, Zhejiang, China
View Trial Details